Background The use of tolerogenic DCs is a promising therapeutic strategy for transplantation
and autoimmune disorders. Immunomodulatory DCs are primarily generated from …

Improper activation of the immune system contributes to a variety of clinical conditions,
including autoimmune and allergic diseases as well as solid organ and bone marrow …

Recently we reported that the human thymus contains a minute population of CD34+CD38dim
cells that do not express the T-cell lineage markers CD2 and CD5. The phenotype of this …

Several mechanisms and cell types are involved in the regulation of the immune response.
These include mostly regulatory T cells (Tregs), regulatory macrophages (Mregs), myeloid …

Dendritic cells (DCs), the most efficient antigen-presenting cells, are necessary for the effective
activation of naïve T cells. DCs can also acquire tolerogenic functions in vivo and in vitro …

Multiple sclerosis (MS) is a chronic demyelinating autoimmune disease of the central nervous
system. Current therapies decrease the frequency of relapses and limit, to some extent, …

Introduction The importance of biomarkers for pharmaceutical drug development and clinical
diagnostics is more significant than ever in the current shift toward personalized medicine. …

… Expression of CD40 (a, b), CD86 (c, d) and MHCII molecule IAIE (e, f) on fresh … María
José Mansilla, Juan Navarro-Barriuso & Eva María Martínez-Cáceres … Eva María Martínez-Cáceres …

Background Treatment with tolerogenic dendritic cells (Tol DC ) is a promising, cell‐based
strategy to regulate autoimmune diseases such as multiple sclerosis ( MS ) in an antigen‐…

Relapses of multiple sclerosis (MS) are treated commonly with high-dose intravenous
methylprednisolone (MP) given over a period of 3–5 days. The mechanisms responsible for the …